DTL
HUMA icon

Dynamic Technology Lab’s Humacyte HUMA Stock Holding History

Dynamic Technology Lab’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-24,734
Closed -$119K – 1154
2024
Q2 		$119K Buy
+24,734
New +$129K 0.01% 841
2021
Q2 		– Sell
-12,041
Closed -$130K – 1298
2021
Q1 		$130K Sell
12,041
-7,959
-40% -$86.9K 0.01% 1012
2020
Q4 		$203K Buy
+20,000
New +$198K 0.03% 827

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dynamic Technology Lab's HUMA Position: Q3 2024 in Review

Dynamic Technology Lab sold out of Humacyte (HUMA) in Q3 2024, closing a stake of 24,734 shares — an estimated $119K sold.

Dynamic Technology Lab first reported a position in HUMA in Q4 2020 and held it in 3 quarters. The position peaked at $203K in Q4 2020. 143 funds tracked by Wall St. Rank hold HUMA as of Q3 2024.

  • Dynamic Technology Lab reported no remaining Humacyte position as of Q3 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 24,734 Humacyte shares in Q3 2024, an estimated $119K.
  • Dynamic Technology Lab first reported a position in Humacyte in Q4 2020 and held it in 3 quarters.
  • Dynamic Technology Lab's Humacyte position peaked at $203K in Q4 2020.
  • 143 funds tracked by Wall St. Rank held Humacyte as of Q3 2024.

Based on Dynamic Technology Lab's 13F filing for Q3 2024, filed 13 Nov 2024.